The 2025 Department of Defense Tenant Satisfaction Housing Survey will launch and be available to Fort Gregg-Adams residents ...

VIENNA, Va., February 20, 2025--CEL-SCI to initiate Multikine Confirmatory Phase 3 Cancer Trial. VIENNA, Va., February 18, 2025--CEL-SCI reports fiscal Q1 2025 financial results: Multikine shows ...

Vor Biopharma's trem-cel offers hope for AML treatment, but financial risks and early-stage progress suggest caution. Learn ...

Allogene Therapeutics expands collaboration with Foresight Diagnostics to advance development activities in Europe, UK, Canada & Australia: South San Francisco, California Thursda ...

--(BUSINESS WIRE)--CEL-SCI Corporation (NYSE American: CVM) today announced it is in the final stages for the launch of its 212-patient Confirmatory Registration Study for Multikine* (Leukocyte ...

The University of Cebu Lapu-Lapu Mandaue (UCLM) Webmasters lived up to their lofty billing as the defending champions in the ...